BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25341584)

  • 21. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.
    Tanner EJ; Garg K; Leitao MM; Soslow RA; Hensley ML
    Gynecol Oncol; 2012 Oct; 127(1):27-31. PubMed ID: 22750260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial stromal sarcoma of uterus.
    Xue WC; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A High-Grade Undifferentiated Endometrial Stromal Sarcoma Presenting as Inversion of the Uterus: A Rare Case.
    Sharma N; Mishra J; Saha A; Kalita A
    J Midlife Health; 2020; 11(1):40-44. PubMed ID: 32684727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors and treatment modalities in uterine sarcoma.
    El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
    Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.
    Sagae S; Susumu N; Viswanathan AN; Aoki D; Backes FJ; Provencher DM; Vaughan M; Creutzberg CL; Kurzeder C; Kristensen G; Lee C; Kurtz JE; Glasspool RM; Small W
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S83-9. PubMed ID: 25341586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of uterine sarcomas.
    Reichardt P
    Ann Oncol; 2012 Sep; 23 Suppl 10():x151-7. PubMed ID: 22987952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.
    Wen KC; Horng HC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):463-71. PubMed ID: 27590365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
    Bronz L; Genton CY; Kunz J; Schreiner WE
    Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on treatment of uterine sarcoma.
    Nam JH; Park JY
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.
    Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
    Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of sarcomas of the uterus.
    Novetsky AP; Powell MA
    Curr Opin Oncol; 2013 Sep; 25(5):546-52. PubMed ID: 23942299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.